BusinessLung Cancer: VeriStrat® Test Identifies Patients with Squamous Cell Carcinoma of the Lung Who Are More Likely to Have Improved Survival on Afatinib TherapyBy Nasdaq OMXJul 10, 2017, 5:09 PM UTC